Press release
Citicoline Market to Witness Growth Acceleration During 2018 to 2028 | Key Players are Alfa Aesar, Cepham Inc., EZ Melts, HL-Pharma US, etc.
In order to dissert the market scenario prevailing across the citicoline market sector, FactMR has evenly presented a comprehensive analysis report on citicoline market to its extensive online repository. With all vital market facets enclosed into this single assessment, readers can learn about different market drivers, opportunities and trends which are likely to influence the overall market space for the citicoline market in the coming years. In addition, factors such as market size, Y-o-Y growth and revenue share are investigated so as to make this research highly authentic and reliable.Request for a Free Sample Report of Concerned Market - https://www.factmr.com/connectus/sample?flag=S&rep_id=2868
Citicoline Market – Key Insights
The citicoline market registered a healthy CAGR of over 7% during the 2013-2017 period on the back of a rapid rise in the geriatric population around the world.
The citicoline market was valued at over US$ 530 million in 2018 and is expected to witness substantial Y-o-Y growth of 8% in 2019.
North America is expected to account for the leading share in citicoline market owing to the presence of numerous players along with availability of modern and sophisticated infrastructure.
Latin America is expected to emerge as a high growth market during the 2018-2028 period with dementia and Alzheimer’s disease incidences in the region increasing at a brisk pace relative to other regions.
What are the Factors Spearheading the Growth of Citicoline Market?
Stressful lifestyles, increasing competition, long working hours, sleep deficiency, and growing geriatric population are fuelling demand for nutraceuticals that enhance cognitive functions. Citicoline is finding increasing usage in nutraceuticals production owing to its negligible toxicity and neuroprotective properties.
Citicoline induces the formation of phospholipids in the brain that are required for efficient functioning of the neural pathways. With incidences of dementia, Alzheimer’s disease, and other neurological disorders on the rise, governments around the world are providing pharmaceutical companies extended support towards the research and development of drugs that could effectively address these issues. Efforts to study citicoline’s efficacy in prevention and potential recovery from cognitive dysfunctioning are gaining momentum.
Citicoline’s potential use in preventing and improving visual capabilities is expected to create steady opportunities for stakeholders. Numerous studies researching the use citicoline in preventing neurodegenerative deterioration of the retina are underway. Role of citicoline in preventing conditions such as diabetes-induced retinal neurodegradation, glaucoma, and amblyopia are being investigated.
Intensifying research towards the use of citicoline in the treatment for addictive disorders is emerging as another opportunity avenue. Studies suggest that citicoline has a significant influence on the dopamine, glutamate, and acetylcholine production in the brain which can potentially be leveraged to treat various symptoms of addiction disorder such as craving, withdrawal symptoms, and impaired cognitive functioning. Additionally, numerous researches suggest the chemical compound can arguably be used to extenuate the neurotoxic effects of drugs and other substances.
Research on increasing the efficacy of citicoline by using it in combination with other chemical compounds is underway. Market players are increasingly investing in the R&D of drugs based on different citicoline combinations to capitalize on the growing demand for neuroprotective drugs for the prevention of diseases such as dementia, Alzheimer’s disease, and other neurological disorders.
Citicoline Market – Competitive Landscape
In order to capitalize on the growing demand for citicoline in functional foods, Kyowa Hakko Bio Co., Ltd., a leading player in the citicoline market, launched two new citicoline powdered supplements and citicoline capsules in 2018.
Intensifying clinical trials for citicoline’s potential use in the treatment of neurological diseases received a substantial boost after research suggested that using the compound with risperidone could effectively relieve primary negative symptoms of schizophrenia.
The pervasive trend of combining citicoline with other compounds to enhance its efficacy continues to drive the citicoline market growth with a study published in 2018 concluding that a combination of citicoline and docosahexaenoic acid exhibit synergistic activities which can substantially boost recovery after transient brain ischemia.
Some of the leading players operating in the citicoline market include Alfa Aesar, Cepham, Inc., EZ Melts, HL-Pharma US, Double Wood LLC, Instas Pharmaceuticals Ltd., Jarrow Formulas, Inc., Kimia Biosciences, Rakshit Drugs Pvt., Ltd., Relentless Improvement LLC, Swanson, Wellona Pharma Private Limited, Healthy Origins, Biochemix Healthcare Pvt., Ltd., Merck KGaA, Grupo Ferrer Internacional, S.A., Piping Rock Health Products, LLC, and NuerAxon Pharma Inc.
Retail Pharmacy Remains a Lucrative Distribution Channel
Increasing consumer awareness about citicoline-based medication and supplements coupled with the trend of retail pharmacy store owners maintaining a diverse portfolio of similar drugs is estimated to prove vital to citicoline market growth with the distribution channel expected to hold a significant share of the citicoline market revenue.
Ask Industry Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=2868
Contact Us
FactMR
11140 Rockville Pike
Suite 400, Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at: https://insiderstribune.com
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Citicoline Market to Witness Growth Acceleration During 2018 to 2028 | Key Players are Alfa Aesar, Cepham Inc., EZ Melts, HL-Pharma US, etc. here
News-ID: 1817031 • Views: …
More Releases from Fact.MR

Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C …
The global insulated drinkware market was valued at US$ 1.39 billion in 2023 and is forecasted to expand at a 6.3% CAGR over the next ten years. Worldwide sales of insulated drinkware are projected to reach US$ 2.57 billion by 2033-end.This robust growth is driven by increasing consumer awareness of sustainability, rising participation in outdoor activities, and the growing demand for reusable, eco-friendly products amid bans on single-use plastics.
The market…

Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…

Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…

Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
More Releases for Citicoline
Citicoline Market Study, Competition Analysis, Industry Trends, Research Report
2025 - Pristine Market Insights, a leading market research firm, announced the release of its latest and comprehensive market research report on citicoline market. The report spans over 500 pages and delivers 10-year market forecast in US dollars (or custom currencies upon request). It provides in-depth analysis of market dynamics (drivers, opportunities, restraints), PESTLE insights, latest industry trends, and demand factors. The report includes segmented market value, share (%), compound…
Citicoline market grows with a CAGR of 13.8% during 2023-2029
The global Citicoline market size was valued at USD 304.6 million in 2022 and is forecast to a readjusted size of USD 751.9 million by 2029 with a CAGR of 13.8% during review period. In a groundbreaking study, the Healthcare Research Institute (HRI) presents an in-depth analysis of the Citicoline Market, shedding light on its current state, key players, segmentation, regional dynamics, and future projections. Citicoline, a vital compound renowned…
Citicoline Market Size, Industry Share, Forecast 2026
Latest Updated Report 2023, The Global Citicoline Market to Growing A CAGR of % during forecast period of 2023-2026. The Market is segmented by Global Citicoline Market Breakdown by Application (Pharma, Non-pharma) by Type (Injection, Tablets, Capsule) and by Geography (North America, South America, Europe, Asia Pacific, MEA).
The Citicoline Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the…
Citicoline Market Competitive Landscape, Growth Factors, Revenue Analysis by 202 …
The Citicoline Market is expected to grow at a CAGR of 8% during the forecast period of 2023 to 2029.
Citicoline induces the formation of phospholipids in the brain that are required for efficient functioning of the neural pathways. With incidences of dementia, Alzheimer's disease, and other neurological disorders on the rise, governments around the world are providing pharmaceutical companies extended support towards the research and development of drugs that could…
Citicoline Market | CAGR of 14.4%
The global Citicoline Market 2020 Report provides fine intelligence that helps market players to compete well against the tough competition on the basis of growth, sales and other various important factors. The research report lays stress on key growth opportunities and market trends apart from important market dynamics including market drivers and challenges. With the help of this report, involved parties can equip themselves to adapt along with the changes…
Citicoline Market Size Grows Vivaciously by 2028 According to New Research Repor …
Increasing consumer awareness about citicoline-based medication and supplements coupled with the trend of retail pharmacy store owners maintaining a diverse portfolio of similar drugs is estimated to prove vital to citicoline market growth with the distribution channel expected to hold a significant share of the citicoline market revenue.
To gain more valuable insights, request a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=2868
Advancements in tablet manufacturing and intensifying research and development focused towards developing tablets with a…